Clinical Study

Randomized Phase II/III Trial Of Surgery And Postoperative Radiation Delivered With Concurrent Cisplatin Versus Docetaxel Versus Docetaxel And Cetuximab For High-Risk Squamous Cell Cancer Of The Head And Neck

Posted Date: Oct 2, 2013

  • Investigator: Kevin Redmond
  • Co-Investigator: Michelle Adams
  • Specialties: Hematology/Oncology, Oncology, Cancer, Radiation Oncology, Surgical Oncology, Head & Neck Cancer
  • Type of Study: Drug

The purpose of the this part of this study is to find out what effects, good and/or bad, one of the following treatments has on you and your cancer. In this part of the study, you will receive one of the following treatments: • Standard treatment: radiation therapy and cisplatin • Investigational treatment: radiation therapy and docetaxel • Investigational treatment: radiation therapy, docetaxel, and cetuximab

Criteria:

To Qualify You Must Have Head And Neck Cancer.

Keywords:

Head And Neck, High Risk, R1216, Squamous Cell Cancer, Null

For More Information:

Uc Cancer Institute
513-584-7698
kastla@ucmail.uc.edu

  • Search Clinical Studies

  • Research in the News

    UC Study Finds Organs from HCV Donors May Be Safe for Liver Transplant

    A UC researcher says livers from HCV patients who test positive for theantibody made to fight the disease may pose a modest risk of infection and beacceptable for transplant